Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Guangzhou Red Cross Hospital | OTHER |
| Guangzhou First People's Hospital | OTHER |
| Gongguan People's Hospital | UNKNOWN |
| Guangzhou Medical University |
Not provided
Not provided
Not provided
Severe pneumonia(SP) is a one of the main causes of death for critically ill patients.Samples of bronchoalveolar lavage fluid (BALF) from SP patients often report positive for herpes simplex virus type 1 (HSV-1) DNA. However, to date, it is unclear the impact and significance of this positive result on SP patients. This study will evaluate the prognostic impact of lower respiratory tract HSV-1 infection/reactivation on ICU severe pneumonia patients.At the same time, by analyzing the risk factors that affect prognosis, we will identify populations with the potential for intervention benefits and provide a basis for further intervention treatment.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Bronchoalveolar Lavage (BAL) via Fiberoptic Bronchoscopy | Diagnostic Test | Bronchoalveolar Lavage (BAL) via Fiberoptic Bronchoscopy
| ||
| throat Swab | Diagnostic Test | A throat swab is a diagnostic sampling technique used to collect microbial specimens from the oropharynx and tonsillar areas. The standardized procedure involves:
|
| Measure | Description | Time Frame |
|---|---|---|
| 30 day mortality rate of critical care patients with severe pneumonia. | From enrollment (Day 1) through Day 30 |
| Measure | Description | Time Frame |
|---|---|---|
| The incidence rate of herpes simplex virus type 1 infection/reactivation in the lower respiratory tract of critical care patients with severe pneumonia | From enrollment (Day 1) through Day 30 | |
| ICU mortality and in-hospital mortality , ICU stay time and length of in-hospital stay |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Study Population Description :Patients with age>18 years old admitted to the ICU who meet the diagnostic criteria for severe pneumonia.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Lili L Tao | Contact | +8613535107553 | taollicu@163.com |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D011014 | Pneumonia |
| D000085343 | Latent Infection |
| ID | Term |
|---|---|
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
Not provided
Not provided
| OTHER |
Not provided
Not provided
Not provided
Bronchoalveolar lavage fluid (BALF) is a sterile saline solution collected from the lungs during a procedure called bronchoalveolar lavage. A thin, flexible tube (bronchoscope) is inserted into the airways, and saline is gently instilled into a specific lung segment. The fluid is then suctioned back, carrying cells, proteins, and microorganisms from the alveoli (tiny air sacs).
BALF is analyzed to diagnose lung infections (e.g., pneumonia), inflammatory diseases (e.g., sarcoidosis), or cancers. It provides critical information about immune cells, pathogens, and biomarkers in the lower respiratory tract.
| From enrollment (Day 1) through the entire ICU stays and in-hospital stays |
| success rate of ventilator withdrawal, ICU non ventilator survival time | From enrollment (Day 1) through Day 30 |